Skip to Content
Merck
  • Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry.

Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry.

Journal of pharmaceutical and biomedical analysis (2012-04-10)
Ming-juan Wang, Jing Xue, Wen-bo Zou, Yan Wang, Chang-qin Hu, Jos Hoogmartens, Erwin Adams
ABSTRACT

Reversed-phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) was used to characterize the components of bitespiramycin, a group of 4"-acylated spiramycins produced by bioengineered strains. In total 38 components were characterized in commercial samples, including 12 impurities that had never been reported before and 12 other that were partially characterized. The structures of these unknown compounds were deduced by comparison of their fragmentation patterns with those of known major components. Their ultraviolet spectra were used to confirm the presence of an α-, β-, γ-, δ-unsaturated butadiene in the macrocyclic lactone. Compared with the classical method, LC/ESI-MS/MS is particularly advantageous in terms of sensitivity and efficiency to characterize minor components at trace levels in multi-component antibiotics.

MATERIALS
Product Number
Brand
Product Description

Spiramycin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Spiramycin
Supelco
Spiramycin from Streptomyces sp., VETRANAL®, analytical standard, mixture of isomers